KR20090023372A - 전립선암의 검출을 위한 단일클론 항-아넥신 ａ3 항체 - Google Patents

전립선암의 검출을 위한 단일클론 항-아넥신 ａ3 항체 Download PDF

Info

Publication number
KR20090023372A
KR20090023372A KR1020087029969A KR20087029969A KR20090023372A KR 20090023372 A KR20090023372 A KR 20090023372A KR 1020087029969 A KR1020087029969 A KR 1020087029969A KR 20087029969 A KR20087029969 A KR 20087029969A KR 20090023372 A KR20090023372 A KR 20090023372A
Authority
KR
South Korea
Prior art keywords
antibody
annexin
tgc
seq
dsm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020087029969A
Other languages
English (en)
Korean (ko)
Inventor
안드레 쉬라텐홀쯔
Original Assignee
프로테오시스 악티엔게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 프로테오시스 악티엔게젤샤프트 filed Critical 프로테오시스 악티엔게젤샤프트
Publication of KR20090023372A publication Critical patent/KR20090023372A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57555—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4718—Lipocortins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Reproductive Health (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • General Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
KR1020087029969A 2006-06-09 2007-06-11 전립선암의 검출을 위한 단일클론 항-아넥신 ａ3 항체 Ceased KR20090023372A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US81208906P 2006-06-09 2006-06-09
US60/812,089 2006-06-09
US85948906P 2006-11-17 2006-11-17
US60/859,489 2006-11-17

Publications (1)

Publication Number Publication Date
KR20090023372A true KR20090023372A (ko) 2009-03-04

Family

ID=38653814

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020087029969A Ceased KR20090023372A (ko) 2006-06-09 2007-06-11 전립선암의 검출을 위한 단일클론 항-아넥신 ａ3 항체

Country Status (13)

Country Link
US (1) US8012697B2 (https=)
EP (1) EP2024748B1 (https=)
JP (1) JP2009540278A (https=)
KR (1) KR20090023372A (https=)
AU (1) AU2007256377B2 (https=)
CA (1) CA2654330A1 (https=)
DE (1) DE07725949T1 (https=)
DK (1) DK2024748T3 (https=)
ES (1) ES2396730T3 (https=)
PL (1) PL2024748T3 (https=)
PT (1) PT2024748E (https=)
RU (1) RU2467335C2 (https=)
WO (1) WO2007141043A2 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1724586A3 (en) * 2005-05-21 2007-07-04 ProteoSys AG Annexin for cancer risk assessment
EP2344544A2 (en) * 2008-09-26 2011-07-20 ProteoSys AG Novel antibodies recognizing native annexin a3
FR2968767B1 (fr) 2010-12-08 2012-12-21 Biomerieux Sa Procede et coffret pour le diagnostic in vitro du cancer de la prostate
WO2013076222A1 (en) 2011-11-23 2013-05-30 Proteosys Ag Differential annexin a3 measurements of serum and blood derivatives or fractions thereof for the diagnosis of prostate cancer
FR2991777B1 (fr) 2012-06-07 2015-08-21 Biomerieux Sa Procede de detection et/ou de dosage de l'annexine a3 d'un mammifere dans le sang ou au moins un de ses derives
WO2015035941A1 (en) * 2013-09-12 2015-03-19 The University Of Hong Kong Use of annexin a3 as a diagnostic and prognostic biomarker and therapeutic target for treating hepatocellular carcinoma
US9470677B2 (en) 2013-11-28 2016-10-18 Samsung Electronics Co., Ltd. Cell with surface coated with ANXA1 and use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4104910C3 (de) 1991-02-18 2000-02-24 Schloemann Siemag Ag Stahlnachbehandlungsanlage
US5136855A (en) 1991-03-05 1992-08-11 Ontario Hydro Heat pump having an accumulator with refrigerant level sensor
WO2003009814A2 (en) * 2001-07-25 2003-02-06 Millennium Pharmaceuticals, Inc. Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer
DE10217254A1 (de) 2002-04-15 2003-10-23 Proteosys Ag Verwendung von Substanzen zur Behandlung von Tumoren
JP5068543B2 (ja) * 2004-02-16 2012-11-07 プロテオジス アクチェンゲゼルシャフト がんに関する診断マーカー
EP1724585A1 (en) * 2005-05-21 2006-11-22 ProteoSys AG Annexin for cancer risk assessment
EP1724586A3 (en) * 2005-05-21 2007-07-04 ProteoSys AG Annexin for cancer risk assessment

Also Published As

Publication number Publication date
US8012697B2 (en) 2011-09-06
EP2024748A2 (en) 2009-02-18
AU2007256377B2 (en) 2012-11-01
WO2007141043A2 (en) 2007-12-13
RU2008152009A (ru) 2010-07-20
ES2396730T3 (es) 2013-02-25
AU2007256377A1 (en) 2007-12-13
CA2654330A1 (en) 2007-12-13
JP2009540278A (ja) 2009-11-19
RU2467335C2 (ru) 2012-11-20
DE07725949T1 (de) 2009-07-02
EP2024748B1 (en) 2012-12-12
DK2024748T3 (da) 2013-03-18
WO2007141043A3 (en) 2008-03-20
PL2024748T3 (pl) 2013-05-31
PT2024748E (pt) 2013-01-16
US20100233160A1 (en) 2010-09-16

Similar Documents

Publication Publication Date Title
JP4806469B2 (ja) ホルマリン固定およびパラフィン包埋された組織においてＭｅｔを結合するモノクローナル抗体および関連する方法
RU2312109C2 (ru) Моноклональное антитело и продуцирующая его гибридома
CN106661110B (zh) 抗muc1抗体或其抗原结合片段及其用途
RU2467335C2 (ru) Моноклональные антитела против аннексина а3 для обнаружения карциномы простаты
AU2005231081A1 (en) RM2 antigen (beta1,4-GaINAc-disialyl-Lc4) as prostate cancer-associated antigen
JP2012524521A (ja) グリコデリンモノクローナル抗体および卵巣癌の検出におけるその使用のための方法
CN108700586A (zh) 用于评估癌症发生的风险的组合物和方法
JPH08506801A (ja) Ｃｄ４４エキソン６に対応するペプチド、そのペプチドに特異的な抗体、および、腫瘍診断にそれらの抗体を使用する方法
KR101777259B1 (ko) En2 단백질을 특이적으로 인식하는 단클론 항체 또는 이를 함유하는 전립선암 진단용 조성물
KR101374758B1 (ko) 항-사이토케라틴 8/18 복합체 자가면역항체를 포함하는 암 진단 마커 및 이의 항원을 포함하는 암 진단용 조성물
KR20080106157A (ko) Ｆａｓ 결합 항체
KR101777254B1 (ko) En2 단백질을 특이적으로 인식하는 특정 항원으로부터 얻어진 단클론 항체 또는 이를 함유하는 전립선암 진단용 조성물
CA2738032A1 (en) Novel antibodies recognizing native annexin a3
JP2022521535A (ja) 前立腺がんのバイオマーカとしてのｂｍｍｆ１ ｒｅｐタンパク質の使用
JP2023145633A (ja) 乳がんのバイオマーカとしてのｂｍｍｆ１ ｒｅｐタンパク質の使用
CN115698718A (zh) 胰腺癌的检测方法和检测试剂
CN114891099B (zh) 一种抗Engrailed-2蛋白单克隆抗体37C3
CN101501501A (zh) 用于检测前列腺癌的抗膜联蛋白a3单克隆抗体
JP2008515871A (ja) 新規ガン関連抗体及び抗原並びにガンの診断におけるそれらの使用
US7928188B2 (en) Antigen polypeptide for the diagnosis and/or treatment of ovarian cancer
WO2022063787A1 (en) Antibodies specific for alpha-1,6-core-fucosylated psa and fucosylated fragments thereof
WO2003020115A2 (en) Methods and compositions for the detection of cancer
HK1160869A (en) Novel antibodies recognizing native annexin a3

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E601 Decision to refuse application
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000